- Stocks
- Healthcare
- NYSE: SYK

Price (delayed)

$349.07

Market cap

$132.74B

P/E Ratio

41.85

Dividend/share

$3.05

EPS

$8.34

Enterprise value

$142.76B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems;

Stryker's EPS has increased by 34% YoY and by 22% from the previous quarter

SYK's net income is up by 34% year-on-year and by 22% since the previous quarter

SYK's P/E is 4.6% above its last 4 quarters average of 40.0 and 3.6% above its 5-year quarterly average of 40.4

SYK's debt is up by 2.4% from the previous quarter

What are the main financial stats of SYK

Market
Valuations
Earnings

Shares outstanding

380.26M

Market cap

$132.74B

Enterprise value

$142.76B

Price to earnings (P/E)

41.85

Price to book (P/B)

7.13

Price to sales (P/S)

6.46

EV/EBIT

38.87

EV/EBITDA

35.11

EV/Sales

6.96

Revenue

$20.5B

EBIT

$3.67B

EBITDA

$4.07B

Free cash flow

$3.14B

Per share
Balance sheet
Liquidity

EPS

$8.34

Free cash flow per share

$8.26

Book value per share

$48.94

Revenue per share

$54

TBVPS

$52.89

Total assets

$39.91B

Total liabilities

$21.32B

Debt

$13B

Equity

$18.59B

Working capital

$4.6B

Debt to equity

0.7

Current ratio

1.58

Quick ratio

0.86

Net debt/EBITDA

2.47

Margins
Efficiency
Dividend

EBITDA margin

19.8%

Gross margin

63.7%

Net margin

15.4%

Operating margin

19%

Return on assets

8.3%

Return on equity

17.9%

Return on invested capital

16.6%

Return on capital employed

11.5%

Return on sales

17.9%

Dividend yield

0.87%

DPS

$3.05

Payout ratio

36.6%

How has the Stryker stock price performed over time

Intraday

-0.78%

1 week

-1.16%

1 month

10.99%

1 year

32.79%

YTD

16.57%

QTD

16.57%

How have Stryker's revenue and profit performed over time

Revenue

$20.5B

Gross profit

$13.06B

Operating income

$3.89B

Net income

$3.17B

Gross margin

63.7%

Net margin

15.4%

The operating income has grown by 37% year-on-year and by 13% since the previous quarter

SYK's net income is up by 34% year-on-year and by 22% since the previous quarter

Stryker's operating margin has increased by 23% YoY and by 10% QoQ

SYK's net margin is up by 20% YoY and by 18% from the previous quarter

What is Stryker's growth rate over time

What is Stryker stock price valuation

P/E

41.85

P/B

7.13

P/S

6.46

EV/EBIT

38.87

EV/EBITDA

35.11

EV/Sales

6.96

Stryker's EPS has increased by 34% YoY and by 22% from the previous quarter

SYK's P/E is 4.6% above its last 4 quarters average of 40.0 and 3.6% above its 5-year quarterly average of 40.4

SYK's P/B is 17% above its 5-year quarterly average of 6.1 and 15% above its last 4 quarters average of 6.2

SYK's equity is up by 12% year-on-year and by 3.8% since the previous quarter

The stock's price to sales (P/S) is 20% more than its 5-year quarterly average of 5.4 and 15% more than its last 4 quarters average of 5.6

The company's revenue rose by 11% YoY and by 3.1% QoQ

How efficient is Stryker business performance

Stryker's ROIC has increased by 42% YoY and by 14% from the previous quarter

The ROA has grown by 28% YoY and by 20% from the previous quarter

Stryker's ROS has increased by 23% YoY and by 11% from the previous quarter

The ROE rose by 21% YoY and by 19% QoQ

What is SYK's dividend history

DPS

$3.05

Dividend yield

0.87%

Payout ratio

36.6%

Recent dividends

How did Stryker financials performed over time

The total assets is 87% greater than the total liabilities

SYK's quick ratio is up by 23% from the previous quarter

The total assets has increased by 8% year-on-year and by 4.9% since the previous quarter

SYK's debt is 30% less than its equity

SYK's equity is up by 12% year-on-year and by 3.8% since the previous quarter

The debt to equity has contracted by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.